S2Medical Financial Statements From 2010 to 2026

S2M Stock  SEK 0.01  0.0004  4.44%   
Analyzing historical trends in various income statement and balance sheet accounts from S2Medical's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting S2Medical's valuation are summarized below:
S2Medical AB does not right now have any fundamental trend indicators for analysis.
Check S2Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among S2Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . S2Medical financial statements analysis is a perfect complement when working with S2Medical Valuation or Volatility modules.
  
This module can also supplement various S2Medical Technical models . Check out the analysis of S2Medical Correlation against competitors.

S2Medical AB Company Return On Equity Analysis

S2Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current S2Medical Return On Equity

    
  -1.93  
Most of S2Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, S2Medical AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, S2Medical AB has a Return On Equity of -1.9284. This is 91.95% lower than that of the Healthcare sector and 77.91% lower than that of the Medical Devices industry. The return on equity for all Sweden stocks is notably higher than that of the company.

S2Medical AB Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining S2Medical's current stock value. Our valuation model uses many indicators to compare S2Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across S2Medical competition to find correlations between indicators driving S2Medical's intrinsic value. More Info.
S2Medical AB is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the S2Medical's earnings, one of the primary drivers of an investment's value.

About S2Medical Financial Statements

S2Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although S2Medical investors may analyze each financial statement separately, they are all interrelated. The changes in S2Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on S2Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
S2Medical AB develops, produces, and sells wound healing products for burns and chronic wounds. The company was founded in 2013 and is headquartered in Linkping, Sweden. S2Medical is traded on Stockholm Stock Exchange in Sweden.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for S2Medical Stock Analysis

When running S2Medical's price analysis, check to measure S2Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy S2Medical is operating at the current time. Most of S2Medical's value examination focuses on studying past and present price action to predict the probability of S2Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move S2Medical's price. Additionally, you may evaluate how the addition of S2Medical to your portfolios can decrease your overall portfolio volatility.